Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas

Cancer. 1990 Feb 1;65(3):422-4. doi: 10.1002/1097-0142(19900201)65:3<422::aid-cncr2820650308>3.0.co;2-y.

Abstract

Extrapulmonary undifferentiated small cell carcinomas, especially those arising in the upper aerodigestive tract, form a group of neoplasms with a clinical behavior which resembles small cell carcinoma of the lung. In 11 patients treated by combination chemotherapy an objective response rate of 82% was achieved for a median duration of 8+ months. Median survival for all patients was 12 months. Long-term survival was observed in those patients with limited disease who achieved a complete response after chemotherapy followed by radiotherapy.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / mortality
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Digestive System Neoplasms / drug therapy
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Genital Neoplasms, Female / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Mitomycins / administration & dosage
  • Neoplasm Staging
  • Neoplasms, Unknown Primary / drug therapy
  • Vincristine / administration & dosage

Substances

  • Mitomycins
  • Bleomycin
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin